Role  ||| S:0 E:5 ||| NN
of  ||| S:5 E:8 ||| IN
SLC26A6-mediated  ||| S:8 E:25 ||| CD
Cl⁻-oxalate  ||| S:25 E:37 ||| CD
exchange  ||| S:37 E:46 ||| NN
in  ||| S:46 E:49 ||| IN
renal  ||| S:49 E:55 ||| JJ
physiology  ||| S:55 E:66 ||| NN
and  ||| S:66 E:70 ||| CC
pathophysiology  ||| S:70 E:86 ||| NN
Although  ||| S:86 E:95 ||| IN
a  ||| S:95 E:97 ||| DT
major  ||| S:97 E:103 ||| JJ
fraction  ||| S:103 E:112 ||| NN
of  ||| S:112 E:115 ||| IN
Cl⁻  ||| S:115 E:119 ||| CD
reabsorption  ||| S:119 E:132 ||| NN
in  ||| S:132 E:135 ||| IN
the  ||| S:135 E:139 ||| DT
proximal  ||| S:139 E:148 ||| JJ
tubule  ||| S:148 E:155 ||| NN
is  ||| S:155 E:158 ||| VBZ
passive  ||| S:158 E:166 ||| JJ
and  ||| S:166 E:170 ||| CC
paracellular ||| S:170 E:182 ||| NN
,  ||| S:182 E:184 ||| ,
there  ||| S:184 E:190 ||| EX
is  ||| S:190 E:193 ||| VBZ
an  ||| S:193 E:196 ||| DT
additional  ||| S:196 E:207 ||| JJ
component  ||| S:207 E:217 ||| NN
of  ||| S:217 E:220 ||| IN
Cl⁻  ||| S:220 E:224 ||| CD
transport  ||| S:224 E:234 ||| NN
that  ||| S:234 E:239 ||| WDT
is  ||| S:239 E:242 ||| VBZ
transcellular ||| S:242 E:255 ||| VBN
.  ||| S:255 E:257 ||| .
A  ||| S:257 E:259 ||| DT
search  ||| S:259 E:266 ||| NN
for  ||| S:266 E:270 ||| IN
possible  ||| S:270 E:279 ||| JJ
mechanisms  ||| S:279 E:290 ||| NNS
that  ||| S:290 E:295 ||| WDT
might  ||| S:295 E:301 ||| MD
mediate  ||| S:301 E:309 ||| VB
Cl⁻  ||| S:309 E:313 ||| CD
uptake  ||| S:313 E:320 ||| NN
into  ||| S:320 E:325 ||| IN
proximal  ||| S:325 E:334 ||| JJ
tubule  ||| S:334 E:341 ||| JJ
cells  ||| S:341 E:347 ||| NNS
led  ||| S:347 E:351 ||| VBN
to  ||| S:351 E:354 ||| TO
the  ||| S:354 E:358 ||| DT
identification  ||| S:358 E:373 ||| NN
of  ||| S:373 E:376 ||| IN
an  ||| S:376 E:379 ||| DT
apical  ||| S:379 E:386 ||| JJ
membrane  ||| S:386 E:395 ||| JJ
Cl--oxalate  ||| S:395 E:407 ||| JJ
exchange  ||| S:407 E:416 ||| NN
activity ||| S:416 E:424 ||| NN
.  ||| S:424 E:426 ||| .
Subsequent  ||| S:426 E:437 ||| JJ
studies  ||| S:437 E:445 ||| NNS
identified  ||| S:445 E:456 ||| VBN
anion  ||| S:456 E:462 ||| JJ
transporter  ||| S:462 E:474 ||| NN
SLC26A6  ||| S:474 E:482 ||| NN
as  ||| S:482 E:485 ||| IN
responsible  ||| S:485 E:497 ||| JJ
for  ||| S:497 E:501 ||| IN
proximal  ||| S:501 E:510 ||| CD
tubule  ||| S:510 E:517 ||| CD
Cl⁻-oxalate  ||| S:517 E:529 ||| CD
exchange  ||| S:529 E:538 ||| NN
activity ||| S:538 E:546 ||| NN
.  ||| S:546 E:548 ||| .
The  ||| S:548 E:552 ||| DT
most  ||| S:552 E:557 ||| RBS
striking  ||| S:557 E:566 ||| JJ
phenotype  ||| S:566 E:576 ||| NN
in  ||| S:576 E:579 ||| IN
Slc26a6  ||| S:579 E:587 ||| CD
null  ||| S:587 E:592 ||| CD
mice  ||| S:592 E:597 ||| NNS
was  ||| S:597 E:601 ||| VBD
calcium  ||| S:601 E:609 ||| JJ
oxalate  ||| S:609 E:617 ||| NNS
urolithiasis  ||| S:617 E:630 ||| VBP
due  ||| S:630 E:634 ||| JJ
to  ||| S:634 E:637 ||| TO
hyperoxaluria ||| S:637 E:650 ||| VB
.  ||| S:650 E:652 ||| .
Hyperoxalemia  ||| S:652 E:666 ||| NNP
and  ||| S:666 E:670 ||| CC
hyperoxaluria  ||| S:670 E:684 ||| NN
in  ||| S:684 E:687 ||| IN
Slc26a6  ||| S:687 E:695 ||| CD
null  ||| S:695 E:700 ||| CD
mice  ||| S:700 E:705 ||| NNS
were  ||| S:705 E:710 ||| VBD
found  ||| S:710 E:716 ||| VBN
to  ||| S:716 E:719 ||| TO
be  ||| S:719 E:722 ||| VB
caused  ||| S:722 E:729 ||| VBN
by  ||| S:729 E:732 ||| IN
defective  ||| S:732 E:742 ||| JJ
intestinal  ||| S:742 E:753 ||| JJ
back-secretion  ||| S:753 E:768 ||| NN
of  ||| S:768 E:771 ||| IN
ingested  ||| S:771 E:780 ||| JJ
oxalate ||| S:780 E:787 ||| NN
.  ||| S:787 E:789 ||| .
These  ||| S:789 E:795 ||| DT
findings  ||| S:795 E:804 ||| NNS
suggested  ||| S:804 E:814 ||| VBD
that  ||| S:814 E:819 ||| DT
inherited  ||| S:819 E:829 ||| NN
or  ||| S:829 E:832 ||| CC
acquired  ||| S:832 E:841 ||| VBN
defects  ||| S:841 E:849 ||| NNS
in  ||| S:849 E:852 ||| IN
SLC26A6  ||| S:852 E:860 ||| NNP
might  ||| S:860 E:866 ||| MD
lead  ||| S:866 E:871 ||| VB
to  ||| S:871 E:874 ||| TO
hyperoxaluria  ||| S:874 E:888 ||| VB
and  ||| S:888 E:892 ||| CC
increased  ||| S:892 E:902 ||| JJ
stone  ||| S:902 E:908 ||| NN
risk ||| S:908 E:912 ||| NN
,  ||| S:912 E:914 ||| ,
and  ||| S:914 E:918 ||| CC
have  ||| S:918 E:923 ||| VBP
motivated  ||| S:923 E:933 ||| VBN
studies  ||| S:933 E:941 ||| NNS
to  ||| S:941 E:944 ||| TO
characterize  ||| S:944 E:957 ||| VB
the  ||| S:957 E:961 ||| DT
role  ||| S:961 E:966 ||| NN
of  ||| S:966 E:969 ||| IN
SLC26A6  ||| S:969 E:977 ||| CD
in  ||| S:977 E:980 ||| IN
oxalate  ||| S:980 E:988 ||| JJ
homeostasis  ||| S:988 E:1000 ||| NN
in  ||| S:1000 E:1003 ||| IN
patients  ||| S:1003 E:1012 ||| NNS
and  ||| S:1012 E:1016 ||| CC
in  ||| S:1016 E:1019 ||| IN
animal  ||| S:1019 E:1026 ||| JJ
models ||| S:1026 E:1032 ||| NNS
.  ||| S:1032 E:1034 ||| .
